Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Need for expanded HPV genotyping for cervical screening
Jack Cuzick, Cosette M. Wheeler
Papillomavirus Research (2016) Vol. 2, pp. 112-115
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing
Andreas C. Chrysostomou, Dora C. Stylianou, Anastasia Constantinidou, et al.
Viruses (2018) Vol. 10, Iss. 12, pp. 729-729
Open Access | Times Cited: 221
Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study
Timothy Palmer, Lynn Wallace, Kevin Pollock, et al.
BMJ (2019), pp. l1161-l1161
Open Access | Times Cited: 211
Commercially available molecular tests for human papillomaviruses: a global overview
Mario Poljak, Anja Oštrbenk Valenčak, Grega Gimpelj Domjanič, et al.
Clinical Microbiology and Infection (2020) Vol. 26, Iss. 9, pp. 1144-1150
Open Access | Times Cited: 118
Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC)
Maria Kyrgiou, Marc Arbyn, Christine Bergeron, et al.
British Journal of Cancer (2020) Vol. 123, Iss. 4, pp. 510-517
Open Access | Times Cited: 109
Role of HPV Genotype, Multiple Infections, and Viral Load on the Risk of High-Grade Cervical Neoplasia
Rachael Adcock, Jack Cuzick, William C. Hunt, et al.
Cancer Epidemiology Biomarkers & Prevention (2019) Vol. 28, Iss. 11, pp. 1816-1824
Open Access | Times Cited: 86
Multiple HPV Infections and Viral Load Association in Persistent Cervical Lesions in Mexican Women
Mariel Araceli Oyervides-Muñoz, Antonio Alí Pérez‐Maya, Celia N. Sánchez-Domínguez, et al.
Viruses (2020) Vol. 12, Iss. 4, pp. 380-380
Open Access | Times Cited: 80
Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
Leticia Torres‐Ibarra, Jack Cuzick, Attila T. Lörincz, et al.
JAMA Network Open (2019) Vol. 2, Iss. 11, pp. e1915781-e1915781
Open Access | Times Cited: 55
Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America
Rita Mariel Correa, Armando Baena, Joan Valls, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0272205-e0272205
Open Access | Times Cited: 31
Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol
Ardashel Latsuzbaia, Severien Van Keer, Davy Vanden Broeck, et al.
Journal of Molecular Diagnostics (2023) Vol. 25, Iss. 12, pp. 957-966
Open Access | Times Cited: 16
Impact of cervical screening by human papillomavirus genotype: Population-based estimations
Jiangrong Wang, K. Miriam Elfström, Camilla Lagheden, et al.
PLoS Medicine (2023) Vol. 20, Iss. 10, pp. e1004304-e1004304
Open Access | Times Cited: 15
Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework
Lan Xu, Anja Oštrbenk, Mario Poljak, et al.
Journal of Clinical Virology (2017) Vol. 98, pp. 37-42
Closed Access | Times Cited: 44
Approaches to triage optimization in HPV primary screening: Extended genotyping and p16/Ki‐67 dual‐stained cytology—Retrospective insights from ATHENA
Mark H. Stoler, Ed Baker, Seán Boyle, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 9, pp. 2599-2607
Open Access | Times Cited: 42
The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium
Jesper Bonde, Ditte Møller Ejegod, Kate Cuschieri, et al.
Journal of Clinical Virology (2018) Vol. 108, pp. 64-71
Open Access | Times Cited: 40
Risk stratification for cervical neoplasia using extended high‐risk HPV genotyping in women with ASC‐US cytology: A large retrospective study from China
Xiang Tao, R. Marshall Austin, Ting Yu, et al.
Cancer Cytopathology (2021) Vol. 130, Iss. 4, pp. 248-258
Closed Access | Times Cited: 31
Clinical significance of extended high-risk human papillomavirus genotyping and viral load in cervical cancer and precancerous lesions
Pingping Su, Jincheng Ma, Lirui Yu, et al.
Gynecology and Obstetrics Clinical Medicine (2023) Vol. 3, Iss. 1, pp. 22-29
Open Access | Times Cited: 12
Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
Jesper Bonde, Fabio Bottari, Valentin Parvu, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 4, pp. 1033-1041
Open Access | Times Cited: 35
How to triage HPV positive cases: Results of four million females
Murat Gültekin, Selin Dundar, Bekir Keskinkılıç, et al.
Gynecologic Oncology (2020) Vol. 158, Iss. 1, pp. 105-111
Closed Access | Times Cited: 29
Cervical cancer, geographical inequalities, prevention and barriers in resource depleted countries (Review)
A.A. Bogdanova, Charles Andrawos, Constantina Constantinou
Oncology Letters (2022) Vol. 23, Iss. 4
Open Access | Times Cited: 19
Impact of high‐risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real‐world data from regional cervical cancer screening program
Andreia Rosário, Ana Rita Sousa, Joana Marinho‐Dias, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 17
Toward 70% cervical cancer screening coverage: Technical challenges and opportunities to increase access to human papillomavirus (HPV) testing
Kathryn A. Kundrod, José Jerónimo, Beatrice Vetter, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 8, pp. e0001982-e0001982
Open Access | Times Cited: 11
Risk‐Based Triage Strategy by Extended HPV Genotyping for Women With LSIL Cytology: A Real‐World Study
Chun Ye, Yi Liu, Hefeng Huang, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 5
Open Access
Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia
Kate T. Simms, Michaela Hall, Megan A. Smith, et al.
PLoS ONE (2017) Vol. 12, Iss. 1, pp. e0163509-e0163509
Open Access | Times Cited: 33
Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
Lan Xu, Elizaveta Padalko, Anja Oštrbenk, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 9, pp. 2704-2704
Open Access | Times Cited: 30
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework
Anja Oštrbenk, Lan Xu, Marc Arbyn, et al.
Journal of Clinical Microbiology (2018) Vol. 56, Iss. 11
Open Access | Times Cited: 28
Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population
Ingrid Baasland, Pål Romundstad, Maj Liv Eide, et al.
PLoS ONE (2019) Vol. 14, Iss. 1, pp. e0210997-e0210997
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top